IRIDEX (IRIX) Set to Announce Quarterly Earnings on Tuesday

IRIDEX (NASDAQ:IRIX) is scheduled to be announcing its earnings results after the market closes on Tuesday, March 5th. Analysts expect the company to announce earnings of ($0.25) per share for the quarter.

Shares of IRIDEX stock opened at $4.71 on Monday. IRIDEX has a 12-month low of $3.72 and a 12-month high of $9.48. The stock has a market capitalization of $64.78 million, a PE ratio of -4.24 and a beta of 1.10.

Get IRIDEX alerts:

A number of equities research analysts have recently issued reports on IRIX shares. Zacks Investment Research downgraded shares of IRIDEX from a “hold” rating to a “sell” rating in a report on Thursday, December 13th. ValuEngine raised shares of IRIDEX from a “hold” rating to a “buy” rating in a report on Tuesday, November 13th. Stifel Nicolaus lowered their price target on shares of IRIDEX from $9.00 to $7.00 and set a “buy” rating on the stock in a report on Friday, January 4th. Finally, Roth Capital reissued a “buy” rating on shares of IRIDEX in a report on Tuesday, February 5th.

In related news, Chairman William M. Moore acquired 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 12th. The shares were bought at an average cost of $4.34 per share, for a total transaction of $43,400.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert Earle Grove acquired 10,857 shares of the firm’s stock in a transaction that occurred on Wednesday, December 12th. The stock was bought at an average price of $4.23 per share, for a total transaction of $45,925.11. Following the completion of the transaction, the director now owns 2,500 shares of the company’s stock, valued at approximately $10,575. The disclosure for this purchase can be found here. Over the last three months, insiders bought 23,357 shares of company stock worth $99,750. Insiders own 4.80% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “IRIDEX (IRIX) Set to Announce Quarterly Earnings on Tuesday” was first published by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at https://www.tickerreport.com/banking-finance/4195060/iridex-irix-set-to-announce-quarterly-earnings-on-tuesday.html.

IRIDEX Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser systems, which are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.

Featured Story: Balance Sheet